XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Gross profit

Annual gross profit:

$166.24M+$30.97M(+22.89%)
December 31, 2024

Summary

  • As of today (September 16, 2025), XERS annual gross profit is $166.24 million, with the most recent change of +$30.97 million (+22.89%) on December 31, 2024.
  • During the last 3 years, XERS annual gross profit has risen by +$129.97 million (+358.31%).
  • XERS annual gross profit is now at all-time high.

Performance

XERS Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

quarterly gross profit:

$59.64M+$8.25M(+16.05%)
June 30, 2025

Summary

  • As of today (September 16, 2025), XERS quarterly gross profit is $59.64 million, with the most recent change of +$8.25 million (+16.05%) on June 30, 2025.
  • Over the past year, XERS quarterly gross profit has increased by +$19.37 million (+48.08%).
  • XERS quarterly gross profit is now at all-time high.

Performance

XERS quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

TTM gross profit:

$202.33M+$19.37M(+10.58%)
June 30, 2025

Summary

  • As of today (September 16, 2025), XERS TTM gross profit is $202.33 million, with the most recent change of +$19.37 million (+10.58%) on June 30, 2025.
  • Over the past year, XERS TTM gross profit has increased by +$50.45 million (+33.21%).
  • XERS TTM gross profit is now at all-time high.

Performance

XERS TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

XERS Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.9%+48.1%+33.2%
3 y3 years+358.3%+191.0%+233.5%
5 y5 years+10000.0%+8092.4%+10000.0%

XERS Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+358.3%at high+191.0%at high+233.5%
5 y5-yearat high>+9999.0%at high+8092.4%at high>+9999.0%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

XERS Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$59.64M(+16.1%)
$202.33M(+10.6%)
Mar 2025
-
$51.39M(+1.5%)
$182.96M(+10.1%)
Dec 2024
$166.24M(+22.9%)
$50.62M(+24.5%)
$166.24M(+9.1%)
Sep 2024
-
$40.67M(+1.0%)
$152.44M(+0.4%)
Jun 2024
-
$40.27M(+16.2%)
$151.88M(+6.9%)
Mar 2024
-
$34.67M(-5.8%)
$142.06M(+5.0%)
Dec 2023
$135.27M(+54.4%)
$36.82M(-8.2%)
$135.27M(+8.0%)
Sep 2023
-
$40.12M(+31.7%)
$125.30M(+14.3%)
Jun 2023
-
$30.45M(+9.2%)
$109.65M(+10.0%)
Mar 2023
-
$27.88M(+3.8%)
$99.69M(+13.8%)
Dec 2022
$87.61M(+141.5%)
$26.85M(+9.8%)
$87.61M(+13.3%)
Sep 2022
-
$24.46M(+19.4%)
$77.30M(+27.4%)
Jun 2022
-
$20.50M(+29.7%)
$60.68M(+32.8%)
Mar 2022
-
$15.80M(-4.5%)
$45.70M(+26.0%)
Dec 2021
$36.27M
$16.54M(+111.0%)
$36.27M(+53.1%)
Sep 2021
-
$7.84M(+42.0%)
$23.69M(+5.7%)
Jun 2021
-
$5.52M(-13.3%)
$22.43M(+27.2%)
DateAnnualQuarterlyTTM
Mar 2021
-
$6.37M(+60.8%)
$17.63M(+58.2%)
Dec 2020
$11.11M(+892.6%)
$3.96M(-39.7%)
$11.15M(+49.7%)
Sep 2020
-
$6.57M(+802.7%)
$7.45M(+526.9%)
Jun 2020
-
$728.00K(-738.6%)
$1.19M(+56.9%)
Mar 2020
-
-$114.00K(-143.7%)
$757.00K(-32.4%)
Dec 2019
$1.12M(-53.8%)
$261.00K(-16.6%)
$1.12M(-32.5%)
Sep 2019
-
$313.00K(+5.4%)
$1.66M(-14.0%)
Jun 2019
-
$297.00K(+19.8%)
$1.93M(-21.3%)
Mar 2019
-
$248.00K(-69.0%)
$2.45M(+1.1%)
Dec 2018
$2.42M(+56.1%)
$801.00K(+37.6%)
$2.42M(+16.0%)
Sep 2018
-
$582.00K(-28.9%)
$2.09M(+24.6%)
Jun 2018
-
$819.00K(+270.6%)
$1.68M(+95.5%)
Mar 2018
-
$221.00K(-52.7%)
$858.00K(-13.4%)
Dec 2017
$1.55M(+45.5%)
$467.00K(+174.7%)
$991.00K(+89.1%)
Sep 2017
-
$170.00K(-52.0%)
$524.00K(+48.0%)
Mar 2017
-
$354.00K
$354.00K
Dec 2016
$1.07M
-
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual gross profit?
  • What is the all time high annual gross profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual gross profit year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly gross profit?
  • What is the all time high quarterly gross profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly gross profit year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. TTM gross profit?
  • What is the all time high TTM gross profit for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. TTM gross profit year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual gross profit?

The current annual gross profit of XERS is $166.24M

What is the all time high annual gross profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual gross profit is $166.24M

What is Xeris Biopharma Holdings, Inc. annual gross profit year-on-year change?

Over the past year, XERS annual gross profit has changed by +$30.97M (+22.89%)

What is Xeris Biopharma Holdings, Inc. quarterly gross profit?

The current quarterly gross profit of XERS is $59.64M

What is the all time high quarterly gross profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly gross profit is $59.64M

What is Xeris Biopharma Holdings, Inc. quarterly gross profit year-on-year change?

Over the past year, XERS quarterly gross profit has changed by +$19.37M (+48.08%)

What is Xeris Biopharma Holdings, Inc. TTM gross profit?

The current TTM gross profit of XERS is $202.33M

What is the all time high TTM gross profit for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high TTM gross profit is $202.33M

What is Xeris Biopharma Holdings, Inc. TTM gross profit year-on-year change?

Over the past year, XERS TTM gross profit has changed by +$50.45M (+33.21%)
On this page